Wafaa El-Sadr, MD, MPH, MPA, global director of ICAP, was noted in a Dec 7 article in POZ magazine which discussed how the national system of HIV clinical trials has been reorganized and refined. Specifically, the new structure divides trials into four distinct networks, each with its own leadership and area of focus with a goal to increase efficiency, reduce costs and allow researchers not only to work better together but also be able to pivot to emergent infectious diseases, such as COVID-19.
A major global health organization that has been improving public health in countries around the world for over 15 years, ICAP works to transform the health of populations through innovation, science, and global collaboration. Based at Columbia University in New York City, where it is part of the Mailman School of Public Health, ICAP has projects in more than 30 countries, working side-by-side with ministries of health and local partners to confront some of the world’s toughest health challenges. Through meaningful research, tailored technical assistance, effective training and education programs, and rigorous surveillance to measure and evaluate the impact of public health interventions, ICAP aims to realize a global vision of healthy people, empowered communities, and thriving societies. Online at icap.columbia.edu